Responding to Drug Recalls Quickly with Intelliguard RFID

Posted on Jun 28, 2017 by Valerie Fritz

On June 15, 2017, it was announced that Hospira is voluntarily recalling “... 42 lots of 8.4% Sodium Bicarbonate Injection, USP, 50 mL vials; 5 lots of NeutTM (Sodium Bicarbonate 4% additive solution) 5 mL vials; 5 lots of QUELICINTM (Succinylcholine Chloride Injection, USP) 200 mg/10 mL vials; and 7 lots of Potassium Phosphates Injection, USP, 45 mM vials to the hospital/retail level.” The recall is "due to a potential for lack of sterility assurance." Those with existing inventory of the recalled lots have been instructed to stop use and distribution immediately. In addition, on June 22nd, a press release was issued to announce that "Advanced Pharma, Inc. d/b/a Avella of Houston Issues Voluntary Nationwide Recall of Specific Lots of Potassium Phosphate and Succinylcholine Repacked and/or Compounded at its Houston Location as a Result of Hospira, Inc's June 15, 2017 Recall of Such Products Due to a Potential Lack of Sterility Assurance."

In order to keep up with the ongoing volume and complexity of drug recalls and ensure patient safety, many hospitals have turned to Intelliguard® RFID pharmacy automation solutions, enabling them to manage recalls more quickly and effectively.

... read more

April Drug Recall: A Quality and Safety Issue for Patients

Posted on Apr 27, 2017 by Valerie Fritz

Hospira Inc., a Pfizer company, recently announced a voluntary recall of “ lot of 25% Dextrose Injection, USP, (Infant) pre-filled syringe to the hospital/user level due to the presence of particulate matter, identified as human hair, found within an internal sample syringe.” Fortunately for patients, hospitals and Hospira, no reports of any adverse events associated with this issue have been received to date. Drug recalls are often a critical patient safety issue. To keep up with the ongoing volume, many hospitals have developed standards and best practices to help ensure patient safety.

... read more